Deucravacitinib has been observed as a safe and efficacious treatment for adults with moderate to severe plaque psoriasis for up to 4 years.

“AI can enhance clinical decision-making for common acute symptoms in a virtual urgent care setting,” the authors write. “Thoughtful integration of AI into clinical practice, combining its strengths ...

Patients with suspected eyelid allergic contact dermatitis can benefit from patch testing beyond common allergens.

Suicide helpline services are underfunded and those seeking help benefit from frequent volunteer training and a quality assurance structure.

Higher waterborne microplastic concentrations in coastal area were associated with increased high blood pressure, diabetes, and stroke.

Several patient-specific factors are associated with an increased rate of advanced melanoma at presentation, including age, gender, and race.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

The Trump administration's overall freeze in funding from the National Institutes of Health may mean fewer new treatments.

Childhood asthma risk may be predicted based on the intensity of respiratory signs and symptoms during the first year of life.

Most patients with hidradenitis suppurativa are dissatisfied with their treatment and do not know about all treatment options.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).